(SCOUT CAP) A Phase IV Double-Blind, Placebo-Controlled, Randomized Trial to Evaluate Short Course vs. Standard Course Outpatient Therapy of Community Acquired Pneumonia in Children Vaccine and Treatment Evaluation Units

Grant

Date/time Interval

  • February 1, 2014 - April 1, 2021

    • Awarded By

    Total Award Amount

  • 115938.00

    • Direct Costs

  • 78072.00

    • Sponsor Award Id

  • 14-0079.B1C1.0028

    • Contributor

  • David Kimberlin M.D.   Principal Investigator  
  • Meghan Angeline   Investigator